Actinium Pharmaceuticals, Inc. — Director's Dealing 2013

Jan 18, 2013

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Cactus Ventures, Inc. (CTVN)
CIK: 0001388320
Period of Report: 2012-12-28

Reporting Person: Memorial Sloan-Kettering Cancer Center (10% Owner)
Reporting Person: AHLB Holdings, LLC (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, par value $0.01 per share	5702387	Indirect

Footnotes

F1: Shares may be deemed to be beneficially owned indirectly by Memorial Sloan-Kettering Cancer Center (" MSKCC ") and its wholly-owned subsidiary, AHLB Holdings, LLC ("AHLB"). AHLB's wholly-owned subsidiary Actinium Holdings Ltd. ("AHL"), a Bermuda corporation, is the record holder of such shares and might have been deemed the direct beneficial owner of such shares; however, it has been dissolved for inadvertant failure to pay annual fees. AHLB has begun the process of applying for the reinstatement of AHL; pending such reinstatement, MSKCC and AHLB may not be able to vote, dispose of or benefit from such shares.